Chiropractors in Zachary, LA Accepting Medicare

6 Chiropractors found. Showing 1 - 6

Dr. Nicole Monique Halkovic, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1121b Church St, Zachary, LA 70791 Phone: 225-654-0048    Fax: 225-654-9906

Dr. William Peay, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 19850 Old Scenic Hwy, Suite 400, Zachary, LA 70791 Phone: 225-719-0985

Chiro/practical Chiropractor Medicare: Medicare Enrolled Practice Location: 5626 Main St, Zachary, LA 70791 Phone: 225-658-0500    Fax: 225-658-9414

Matthew James Simonson, D. C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 5626 Main Street, Zachary, LA 70791 Phone: 225-658-0500    Fax: 225-658-9414

Zachary Spine And Sports Rehabilitation Chiropractor Medicare: Medicare Enrolled Practice Location: 19850 Old Scenic Hwy, Ste 400, Zachary, LA 70791 Phone: 225-719-0985

Zachary Chiropractic Clinic, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 1121 Church St, Suite B, Zachary, LA 70791 Phone: 225-654-0048    Fax: 225-654-9906

News Archive

Dentists concerned about gaps in health law coverage; Mass. effort for small business insurance hampered by federal law

The federal overhaul requires dental care for children but advocates say the mechanism for that will often be complicated. Meanwhile, in a different article about the complications of implementing the health law, the Boston Globe examines efforts by small businesses to buy insurance.

Vascular Solutions acquires EXPRO Elite and MICRO Elite snare products from Radius

Vascular Solutions, Inc. today announced that it has acquired the assets related to the EXPRO Elite™ and MICRO Elite™ snare products from Radius Medical Technologies, Inc. and its subsidiary, Radius Medical, LLC. Vascular Solutions has been selling the EXPRO Elite™ and MICRO Elite™ snares in the U.S. under a distribution relationship with Radius since 2008, while in international markets Radius has been selling the products through a network of independent distributors.

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer.

TSRI scientists discover potential drug candidate to suppress pain and itch

In a new study, scientists from the Florida campus of The Scripps Research Institute have identified a possible drug candidate that suppresses pain and itch in animal models.

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

The unchecked advance of COVID-19 has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: SARS-CoV-2. An encouraging new study shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus (NDV)-based intranasal vector vaccine in animal studies.

Read more Medical News

› Verified 8 days ago